Do you want to read an article? Please log in or register.
Testosterone Therapy in Men With Hypogonadism Prevents Progression From Prediabetes to Type 2 Diabetes: Eight-Year Data From a Registry Study
Type 2 Diabetes
COMMENTED
Related content
COMMENTED
Further Publications
Testosterone treatment to prevent or revert type 2 diabetes in men enrolled in a lifestyle programme (T4DM): a randomised, double-blind, placebo-controlled, 2-year, phase 3b trial
★ 2
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
Lancet Diabetes Endocrinol
Wittert G, Bracken K, Robledo KP, Grossmann M, Yeap BB, Handelsman DJ, Stuckey B, Conway A, Inder W, McLachlan R, Allan C, Jesudason D, Fui MNT, Hague W, Jenkins A, Daniel M, Gebski V, Keech A
doi: 10.1016/S2213-8587(20)30367-3
Diabetes - GeneralType 2 DiabetesGlycemic ControlHypogonadismObesity and Bariatric Surgery
Testosterone therapy of men with type 2 diabetes mellitus - a randomized, double-blinded, placebo-controlled study
Dan Med J.
Magnussen LV
COMMENTED
Type 2 Diabetes
A Type 1 Diabetes Genetic Risk Score Can Identify Patients With GAD65 Autoantibody-Positive Type 2 Diabetes Who Rapidly Progress to Insulin Therapy
Diabetes Care.
Grubb AL, McDonald TJ, Rutters F, Donnelly LA, Hattersley AT, Oram RA, Palmer CNA, van der Heijden AA, Carr F, Elders PJM, Weedon MN, Slieker RC, 't Hart LM, Pearson ER, Shields BM, Jones AG
doi: 10.2337/dc18-0431.
RECOMMENDED
Type 1 DiabetesType 2 DiabetesPediatric Diabetes
Disordered Eating Behaviors in Youth and Young Adults With Type 1 or Type 2 Diabetes Receiving Insulin Therapy: The SEARCH for Diabetes in Youth Study
Diabetes Care.
Nip ASY, Reboussin BA, Dabelea D, Bellatorre A, Mayer-Davis EJ, Kahkoska AR, Lawrence JM, Peterson CM, Dolan L, Pihoker C, SEARCH for Diabetes in Youth Study Group
doi: 10.2337/dc18-2420.
Type 2 Diabetes
Intermediate hyperglycaemia to predict progression to type 2 diabetes (ELSA-Brasil): an occupational cohort study in Brazil
Lancet Diabetes Endocrinol.
Inês Schmidt M, Bracco PA, Yudkin JS, Bensenor IM, Härter Griep R, Maria Barreto S, Castilhos CD, Duncan BB
doi: 10.1016/S2213-8587(19)30058-0.
Diabetes - GeneralType 2 Diabetes
Determinants of 20-year non-progression to Type 2 diabetes in women at very high risk: the E3N cohort study
Diabet Med.
Fagherazzi G, Gusto G, Mancini FR, Dow C, Rajaobelina K, Balkau B, Boutron-Ruault MC, Bonnet F
doi: 10.1111/dme.13774.
COMMENTED
Diabetes - GeneralType 2 DiabetesDiabetes and Pregnancy
Metformin for diabetes prevention: insights gained from the Diabetes Prevention Program/Diabetes Prevention Program Outcomes Study
Diabetologia.
Aroda VR, Knowler WC, Crandall JP, Perreault L, Edelstein SL, Jeffries SL, Molitch ME, Pi-Sunyer X, Darwin C, Heckman-Stoddard BM, Temprosa M, Kahn SE, Nathan DM; Diabetes Prevention Program Research Group
doi: 10.1007/s00125-017-4361-9.
Type 2 Diabetes
Time-varying risk of microvascular complications in latent autoimmune diabetes of adulthood compared with type 2 diabetes in adults: a post-hoc analysis of the UK Prospective Diabetes Study 30-year follow-up data (UKPDS 86)
Lancet Diabetes Endocrinol.
Maddaloni E, Coleman RL, Agbaje O, Buzzetti R, Holman RR
doi: 10.1016/S2213-8587(20)30003-6.
Type 1 DiabetesType 2 Diabetes
Prevalence of and Risk Factors for Diabetic Peripheral Neuropathy in Youth With Type 1 and Type 2 Diabetes: SEARCH for Diabetes in Youth Study
Diabetes Care.
Jaiswal M, Divers J, Dabelea D, Isom S, Bell RA, Martin CL, Pettitt DJ, Saydah S, Pihoker C, Standiford DA, Dolan LM, Marcovina S, Linder B, Liese AD, Pop-Busui R, Feldman EL
doi: 10.2337/dc17-0179.